A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD.
Cites articles 20
- 2005-03-01
- 1993-10-01
Date
Title
Article - wd:Q36787818
Article - wd:Q36787818